Diffusion Tensor Imaging to Judge the Prognosis of Patients With Diffuse Axonal Injury

Diffusion Tensor Imaging to Judge the Prognosis of Patients With Diffuse Axonal

The investigators will examine 15 patients who was firstly diagnosed as diffuse axonal injury and 15 patients negative for magnetic resonance examination with no trauma with DTI(diffusion tensor imaging). The investigators then determine the FA(fractional anisotropy)value and the ADC(apparent diffusion coefficient) value of relational interesting area(corpus callosum、brainstem、basal ganglia)to analyse the correlation between the FA(fractional anisotropy)value and ADC(apparent diffusion coefficient) value and GCS(Glasgow Coma Scale) and coma time,so that the investigators can quantify the damage degree of patients' white matter fiber.By using fiber tractography the investigators can have the extent of recovery of the patient of DAI(diffuse axonal injury) in real-time detection and give guidance for the clinical decision and the judgement of prognosis).

Study Overview

Status

Unknown

Detailed Description

The investigators will examine 15 patients who was firstly diagnosed as diffuse axonal injury and 15 patients negative for magnetic resonance examination with no trauma with DTI(diffusion tensor imaging). The investigators then determine the FA(fractional anisotropy)value and the ADC(apparent diffusion coefficient) value of relational interesting area(corpus callosum、brainstem、basal ganglia)to analyse the correlation between the FA(fractional anisotropy)value and ADC(apparent diffusion coefficient) value and GCS(Glasgow Coma Scale) and coma time,so that the investigators can quantify the damage degree of patients' white matter fiber.At the same time the investigators rebuild the white matter fiber tract(corpus callosum 、corticospinal tract、optic radiation) of patients using diffusion tensor tractography so that the investigators can judge intuitively the extent of damage and recovery. The investigators Trace the repair of nerve fibers after treatment and guide the further treatment.This trial can exactly determine the relationship between the FA(fractional anisotropy)value and ADC(apparent diffusion coefficient) value in relational interesting area and the extent of damage in patient of DAI(diffuse axonal injury).Meanwhile the trial confirms that the DTI(diffusion tensor imaging) can exactly judge the prognosis of DAI(diffuse axonal injury).Obviously by using fiber tractography the investigators can have the extent of recovery of the patient of DAI(diffuse axonal injury) in real-time detection and give guidance for the clinical decision and the judgement of prognosis).

Study Type

Observational

Enrollment (Anticipated)

30

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The patient who attend to be diagnosed as diffuse axonal injury with closed craniocerebral injury caused by a traffic accident or a fall injury)

Description

Inclusion Criteria:

  • Has a history of trauma exactly
  • Immediate coma after injury
  • Increased intracranial pressure level do not agree with clinical illness severity
  • No significant changes of CT while with severe clinical manifestations

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
experimental group
patients who was firstly diagnosed as diffuse axonal injury
control group
patients negative for magnetic resonance examination with no trauma

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in FA(fractional anisotropy)
Time Frame: Change from FA(fractional anisotropy) within 2 weeks
Change from FA(fractional anisotropy) within 2 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in ADC(apparent diffusion coefficient)
Time Frame: Change from ADC(apparent diffusion coefficient) within 2 weeks
Change from ADC(apparent diffusion coefficient) within 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Anticipated)

August 1, 2018

Study Completion (Anticipated)

August 1, 2018

Study Registration Dates

First Submitted

April 15, 2016

First Submitted That Met QC Criteria

July 28, 2016

First Posted (Estimate)

August 2, 2016

Study Record Updates

Last Update Posted (Estimate)

August 2, 2016

Last Update Submitted That Met QC Criteria

July 28, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diffuse Axonal Injury

3
Subscribe